AxoGen, Inc. (AXGN) vs BioLife Solutions, Inc. (BLFS)
A side-by-side comparison of AxoGen, Inc. and BioLife Solutions, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
AXGN
AxoGen, Inc.
$36.60HealthcareDelayed quote: Oct 6, 2026, 10:35 AM EDT
BLFS
BioLife Solutions, Inc.
$38.61HealthcareDelayed quote: Oct 5, 2026, 4:00 PM EDT
Total return — AXGN vs BLFS
growth of $100 · dividends reinvested · last 10yAXGN +326.8% (+15.6%/yr)BLFS +2119.0% (+36.3%/yr)BLFS compounded faster over this window
Log scale — wide-divergence pair
AXGN BLFS
AXGN vs BLFS: by the numbers
- •AXGN is the larger company ($1.97B vs $1.89B market cap).
- •BLFS is profitable (49.06% net margin) while AXGN runs a net loss (-13.36%).
- •AXGN grew revenue faster over the past five years (13.99% vs 6.78% CAGR).
Metrics side by side
Valuation
| Metric | AXGN | BLFS |
|---|---|---|
| P/E ratio | N/A | 37.72 |
| Forward P/E | 82.72 | 64.35 |
| P/S ratio | 7.83 | 18.35 |
| P/B ratio | 7.68 | 4.49 |
| EV / EBITDA | N/A | 170.26 |
| FCF yield | 0.13% | N/A |
Profitability
| Metric | AXGN | BLFS |
|---|---|---|
| Gross margin | 74.56% | 64.48% |
| Operating margin | -5.12% | -1.12% |
| Net margin | -13.36% | 49.06% |
| ROE | -13.09% | 12.01% |
| ROIC | -4.68% | 1.72% |
Growth (annualized)
| Metric | AXGN | BLFS |
|---|---|---|
| Revenue CAGR (5Y) | 13.99% | 6.78% |
| Total return CAGR (5Y) | 19.40% | -0.77% |
Frequently asked
- Which has grown faster, AXGN or BLFS?
- Over the past five years, AXGN grew revenue faster — AXGN at a 13.99% CAGR versus BLFS at 6.78%.
- Is AXGN or BLFS more profitable?
- BLFS runs the higher net margin — AXGN at -13.36% versus BLFS at 49.06%.
- How have AXGN and BLFS total returns compared?
- Over the past 10 years, AXGN delivered 15.98% and BLFS delivered 36.27% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
BioLife Solutions P/E ratioAxoGen ROEBioLife Solutions ROEAxoGen operating marginBioLife Solutions operating marginAxoGen revenue growthBioLife Solutions revenue growthAxoGen free cash flowBioLife Solutions free cash flow
AxoGen & BioLife Solutions appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.